RDHL - RedHill Biopharma Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4344
Avg. Estimate-0.24-0.15-1.07-0.59
Low Estimate-0.33-0.26-1.4-0.93
High Estimate-0.03-0.02-0.14-0.03
Year Ago EPS-0.3-0.35-1.7-1.07
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5366
Avg. Estimate2.2M7.5M6.92M42.04M
Low Estimate1.26M5.5M5.96M20.26M
High Estimate3.6M9.6M8.3M56.6M
Year Ago Sales1.36M1.74M8.36M6.92M
Sales Growth (year/est)61.90%331.80%-17.20%507.50%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.38-0.27-0.29-0.4
EPS Actual-0.3-0.35-0.4-0.35
Difference0.08-0.08-0.110.05
Surprise %21.10%-29.60%-37.90%12.50%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.24-0.15-1.07-0.59
7 Days Ago-0.24-0.15-1.07-0.59
30 Days Ago-0.24-0.15-1.07-0.59
60 Days Ago-0.24-0.15-1.07-0.59
90 Days Ago-0.35-0.26-1.46-0.99
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRDHLIndustrySectorS&P 500
Current Qtr.20.00%N/AN/AN/A
Next Qtr.57.10%N/AN/A0.08
Current Year37.10%N/AN/A0.01
Next Year44.90%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A